Immune-mediated Thrombocytopenic Purpura
1 clinical trials · Condition
◉ Watch Immune-mediated Thrombocytopenic Purpura
| Record | Firm | Date |
|---|---|---|
| Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP) (NCT05263193) | Sanofi | 2022-06-08 |
Track Immune-mediated Thrombocytopenic Purpura automatically
Every clearance here is in the API, with alerts when new ones post.